Quantum Innovations Secures €9.4 Million to Revolutionize Cardiac Surgery Monitoring

Warsaw-based Quantum Innovations has successfully raised €9.4 million in its second funding round to develop cutting-edge technology for monitoring cardiac surgeries. The round was led by Vinci IQ ASI, a fund established by BGK and managed by Vinci S.A., with participation from the company’s existing investor, MedTech Holding.

Under the leadership of Grzegorz Suwalski, M.D, PhD, the team has created the world’s first sensor technology capable of monitoring organs during surgery and transplantation. Their Heart Sense solution enables real-time ECG monitoring directly from the surface of a beating heart. Additionally, the Heart Guard technology tracks tissue metabolism, even during periods when the heart is stopped for cardiac surgery.

The capital raised in this financing round will be utilized to establish an in-house production line, conduct regulatory and clinical trials, obtain necessary certifications, and enter major global markets.

Cardiac surgery represents one of the most dynamically evolving fields of medicine, with numerous breakthroughs and innovations over the past century. This includes not only the first heart transplant but also the introduction of heart valves, vascular sutures, coronary artery bypass grafts (CABG), and various minimally invasive procedures such as transcatheter aortic valve implantation (TAVI). Despite these advances, cardiovascular diseases remain one of the leading causes of mortality in developed countries. According to the latest World Heart Report 2023, over half a billion people worldwide suffer from cardiovascular diseases, which account for nearly 20.5 million deaths, representing approximately 30% of all deaths. A recent study by iData Research also indicates that around 900,000 cardiac surgeries are performed annually in the U.S., with this number expected to rise to 1.3 million by 2029.

The development of medical technologies significantly enhances the success rate of cardiothoracic surgeries while reducing complications and mortality rates. Surgeries, especially those involving internal organs, require extreme precision and continuous monitoring. None of the currently available tools or equipment provide such capabilities. The technology developed by Quantum Innovations aims to fill this gap.

Grzegorz Suwalski, the Founder and CEO of Quantum Innovations, explained, “Acquiring new and previously inaccessible precise signals from the organs and body parts undergoing surgery pushes the boundaries of our knowledge. Overcoming these barriers opens up prospects for improving medical procedures. Thus, Heart Sense technology makes it possible to examine the ECG of the operated heart, in any of its positions, from any of its walls, directly from its surface. Heart Guard technology, on the other hand, monitors the metabolism-dependent acidification of the heart. Studies indicate that using this data can help cardiac teams overcome knowledge gaps and prevent dangerous complications and fatalities in patients.”

The funding raised by the Quantum Innovations team will be used to develop and set up a production line in a clean-room environment, as well as to conduct necessary certifications, including regulatory and clinical trials on humans, which will help bring the product to global markets.

Piotr Wolinski, President of Vinci S.A., which manages the Vinci IQ ASI fund, commented, “We were convinced to invest primarily by the groundbreaking product and technology, as well as the practical experience of the team. The solutions proposed by QI address an unmet need in clinical practice during cardiothoracic surgeries. Introducing these solutions into medical standards has the potential to significantly reduce complications and perioperative mortality associated with heart surgeries. Investments in medical technologies like QI fit perfectly with our fund’s mission of supporting sustainable development.”

The successful funding round of Quantum Innovations highlights the promising future of medical technology advancements in cardiac surgery, setting the stage for further innovations that could potentially save countless lives.